中西医结合治疗COPD合并慢性肺心病50例

目的:探讨中西医结合治疗稳定期慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)合并肺心病的临床疗效.方法:将明确诊断为稳定期COPD合并肺心病的100例患者随机分为对照组及观察组各50例,对照组仅给予正规西医治疗；观察组则在对照组的治疗基础上结合中医理论,加用中药进行综合治疗.两组均在治疗4周后评价疗效.结果:治疗4周后,观察组无论是对慢性肺心病的疗效(总有效率94％)还是对呼吸系统症状改善(总有效率为82％)都明显优于对照组(总有效率分别是76％和74％,P＜0.01或P＜0.05).SGRQ评分发现,观察组患者的生活质量较治疗前有了明显提高(P＜0.01).结论:中西医结合治疗COPD合并肺心病优势明显,可提高该病的临床疗效,提高患者的生活质量.

Integrative Medicine Treatment 50 Cases of COPD with Chronic Pulmonary Heart Disease

Objective: To investigate the Integrative Medicine clinical efficacy of treatment with stationary phase chronic obstructive pulmonary disease (COPD) with pulmonary heart disease. Method: A clear diagnosis of stationary phase COPD with pulmonary heart disease, 100 patients were randomly divided into control group of 50 cases and the observation group of 50 cases, the control group only received the formal Western medical treatment;the observation group in the control group treatment program combined with traditional Chinese medicine theory, with traditional Chinese medicine to carry out comprehensive treatment. Both groups were at least 4 weeks of treatment to be evaluated. Result: After 4 weeks of treatment, the observation group, whether the efficacy of chronic pulmonary heart disease (total efficiency of 94%) or respiratory symptoms improved (total effective rate of 82%) are significantly better than the control group only to Western medicine treatment (total efficiency of 76% and 74% respectively, P<0.01 or P<0.05). In addition, the SGRQ score showed that the patients by the integrative medicine has been markedly improved quality of life of the observation group than before treatment (P<0.01). Conclusion: Integrative treatment of COPD with pulmonary heart disease have obvious advantages, can effectively increase the clinical efficacy of the disease, improve the quality of life of patients.